Rifampin-Associated Pseudomembranous Colitis
- 1 August 2009
- journal article
- case report
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 338 (2) , 156-158
- https://doi.org/10.1097/maj.0b013e31819f1eec
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Clinical Recognition and Diagnosis ofClostridium difficileInfectionClinical Infectious Diseases, 2008
- Clinical Aspects of Rifampicin-associated Pseudomembranous ColitisJournal of Clinical Gastroenterology, 2007
- Resistance determinants in strains of Clostridium difficile from two geographically distinct populationsInternational Journal of Antimicrobial Agents, 2004
- A Case of Pseudomembranous Colitis Associated with RifampinThe Korean Journal of Internal Medicine, 2004
- Antimicrobial Susceptibilities and Serogroups of Clinical Strains of Clostridium difficile Isolated in France in 1991 and 1997Antimicrobial Agents and Chemotherapy, 1999
- Pseudomembranous colitis in a patient treated with ofloxacin for tuberculosisTubercle and Lung Disease, 1996
- Diarrhoea associated with Clostridium difficile in AIDS patients receiving rifabutinThe Lancet, 1994
- Clarithromycin and pseudomembranous enterocolitisThe Lancet, 1994
- A Case of Clostridium difficile Colitis Induced by RifampicinKansenshogaku Zasshi, 1985
- Antibiotic associated diarrhoea probably related to rifampicinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983